Hepatocellular carcinoma: New and emerging risks

被引:22
作者
Sherman, Morris [1 ,2 ]
机构
[1] Univ Toronto, Dept Med, Toronto, ON M5N 2N2, Canada
[2] Univ Hlth Network, Toronto, ON M5N 2N2, Canada
关键词
Cirrhosis; Hepatitis B; Hepatitis C; Hepatocellular carcinoma;
D O I
10.1016/S1590-8658(10)60508-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The underlying liver diseases that put patients at risk for the development of hepatocellular carcinoma (HCC) are well known. However, it is equally well known that not all patients with these conditions will develop HCC. Therefore within the disease groups (hepatitis B, cirrhosis, etc.,) there are other factors that indicate greater or lesser risk. Some markers of risk are common to all causes of HCC, such as cellular dysplasia, advancing age and male gender. Others factors are specific to individual diseases. This has been well established for hepatitis B in which viral load, genotype and antigen status are major contributors to increased risk of HCC. For both hepatitis B and hepatitis C attempts have been made to identify those individuals at greatest risk using data from large cohort studies. In addition to the common causes of liver disease that are recognized to be causes of HCC non-alcoholic fatty liver disease and possibly diabetes are newly emerging risk factors. (C) 2010 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:S215 / S222
页数:8
相关论文
共 79 条
[51]   The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response [J].
Rehermann, B ;
Ferrari, C ;
Pasquinelli, C ;
Chisari, FV .
NATURE MEDICINE, 1996, 2 (10) :1104-1108
[52]   Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis [J].
Ripoll, Cristina ;
Groszmann, Roberto J. ;
Garcia-Tsao, Guadalupe ;
Bosch, Jaime ;
Grace, Norman ;
Burroughs, Andrew ;
Planas, Ramon ;
Escorsell, Angels ;
Carlos Garcia-Pagan, Juan ;
Makuch, Robert ;
Patch, David ;
Matloff, Daniel S. .
JOURNAL OF HEPATOLOGY, 2009, 50 (05) :923-928
[53]  
RUBIN EM, 1994, MODERN PATHOL, V7, P677
[54]   Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients [J].
Sánchez-Tapias, JM ;
Costa, J ;
Mas, A ;
Bruguera, M ;
Rodés, J .
GASTROENTEROLOGY, 2002, 123 (06) :1848-1856
[55]  
SHERMAN M, 1995, HEPATOLOGY, V22, P432, DOI 10.1002/hep.1840220210
[56]   Recurrence of Hepatocellular Carcinoma [J].
Sherman, Morris .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (19) :2045-2047
[57]   Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients [J].
Squadrito, G ;
Pollicino, T ;
Cacciola, I ;
Caccamo, G ;
Villari, D ;
La Masa, T ;
Restuccia, T ;
Cucinotta, E ;
Scisca, C ;
Magazzu, D ;
Raimondo, G .
CANCER, 2006, 106 (06) :1326-1330
[58]  
Stern MC, 2001, CANCER EPIDEM BIOMAR, V10, P617
[59]   Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: A prospective study of 12,008 men in Taiwan [J].
Sun, CA ;
Wu, DM ;
Lin, CC ;
Lu, SN ;
You, SL ;
Wang, LY ;
Wu, MH ;
Chen, CJ .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (08) :674-682
[60]  
Takahashi Y, 1987, Nihon Geka Gakkai Zasshi, V88, P696